Shelley L. Forrest, Jillian J. Kril, Claire H. Stevens, John B. Kwok, Marianne Hallupp, Woojin S. Kim, Yue Huang, Ciara V. McGinley, Hellen Werka, Matthew C. Kiernan, Jürgen Götz, Maria Grazia Spillantini, John R. Hodges, Lars M. Ittner, Glenda M. Halliday. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies. Brain 2018; 141: 521–534; doi: 10.1093/brain/awx328.
The authors would like to apologize for an error in the abstract. The sentence:
Ten FTLD-tau cases with a MAPT mutation (K257T, S3035S, P301L, IVS10+16, R406W) were screened for the core differentiating neuropathological features used to diagnose the different sporadic FTLD-tau subtypes to determine whether the categorical separation of MAPT mutations from sporadic FTLD-tau is valid.
should read as follows:
Ten FTLD-tau cases with a MAPT mutation (K257T, S305S, P301L, IVS10+16, R406W) were screened for the core differentiating neuropathological features used to diagnose the different sporadic FTLD-tau subtypes to determine whether the categorical separation of MAPT mutations from sporadic FTLD-tau is valid.
This error has been corrected online.